TriVirix, a startup medical device contract manufacturer, has gone the alternative route to getting additional capital.
TriVirix announced today that it has secured a $2.5 million line of credit from Comerica (NYSE: CMA). TriVirix said the funds will be used for working capital.
Aurora Funds is among TriVirix’s venture capital investors.
